BR9606925A - Utilização de compostos e processo para o tratamento e profilaxia da obesidade - Google Patents

Utilização de compostos e processo para o tratamento e profilaxia da obesidade

Info

Publication number
BR9606925A
BR9606925A BR9606925A BR9606925A BR9606925A BR 9606925 A BR9606925 A BR 9606925A BR 9606925 A BR9606925 A BR 9606925A BR 9606925 A BR9606925 A BR 9606925A BR 9606925 A BR9606925 A BR 9606925A
Authority
BR
Brazil
Prior art keywords
prophylaxis
obesity
compounds
treatment
Prior art date
Application number
BR9606925A
Other languages
English (en)
Inventor
Niels Korsgaard
Michel Shalmi
Steven Bain
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9606925A publication Critical patent/BR9606925A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
BR9606925A 1995-01-20 1996-01-10 Utilização de compostos e processo para o tratamento e profilaxia da obesidade BR9606925A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK6695 1995-01-20
DK77495 1995-06-30
PCT/DK1996/000011 WO1996022092A1 (en) 1995-01-20 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity

Publications (1)

Publication Number Publication Date
BR9606925A true BR9606925A (pt) 1997-11-11

Family

ID=26063228

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606925A BR9606925A (pt) 1995-01-20 1996-01-10 Utilização de compostos e processo para o tratamento e profilaxia da obesidade

Country Status (14)

Country Link
US (1) US6008242A (pt)
EP (1) EP0804187A1 (pt)
JP (1) JPH10512270A (pt)
KR (1) KR19980701547A (pt)
CN (1) CN1168099A (pt)
AU (1) AU4328996A (pt)
BR (1) BR9606925A (pt)
CA (1) CA2208837A1 (pt)
CZ (1) CZ211997A3 (pt)
HU (1) HUP9800334A3 (pt)
IL (1) IL116826A (pt)
NO (1) NO973340L (pt)
TW (1) TW448046B (pt)
WO (1) WO1996022092A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO1999002152A1 (en) * 1997-07-10 1999-01-21 Novo Nordisk A/S Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for increasing insulin sensitivity
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2407462B1 (en) 2004-09-21 2014-07-30 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
CA2816322A1 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
MY195739A (en) 2014-02-07 2023-02-08 Novogen ltd Functionalised Benzopyran Compounds and use Thereof
CA2974123C (en) 2015-02-02 2023-08-01 Mei Pharma, Inc. Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
CA2208837A1 (en) 1996-07-25
TW448046B (en) 2001-08-01
WO1996022092A1 (en) 1996-07-25
NO973340D0 (no) 1997-07-18
EP0804187A1 (en) 1997-11-05
JPH10512270A (ja) 1998-11-24
MX9705378A (es) 1997-10-31
IL116826A0 (en) 1996-05-14
IL116826A (en) 1999-11-30
US6008242A (en) 1999-12-28
KR19980701547A (ko) 1998-05-15
NO973340L (no) 1997-07-18
CZ211997A3 (en) 1997-12-17
AU4328996A (en) 1996-08-07
HUP9800334A2 (hu) 1998-12-28
CN1168099A (zh) 1997-12-17
HUP9800334A3 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9400571A (pt) Processo para o tratamento de despejo orgânico
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
BR9510077A (pt) Aparelho e processo para tratamento e distribuição de águas servidas
BR9612203A (pt) Amidas tricíclicas úteis para a inibição da função da g-pro-teína e para o tratamento de doenças proliferativas
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
PT936859E (pt) Composicao e metodo para o tratamento de plantas com quimicos exogenos
BR9204375A (pt) Composicao e processo para o tratamento de agua de refrigeracao
AR002336A1 (es) Proceso para el tratamiento de gas efluente
BR9604959A (pt) Composição e método para o tratamento de desensibilização de dentes
BR9506271A (pt) Processo para o tratamento de aves domésticas
NO965563D0 (no) Behandling og profylakse av osteoporese
BR9508584A (pt) Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia
PT100916A (pt) Processo para o tratamento de carne
BR9607413A (pt) Processo para produçao de pentafluoretano e tetrafluorcloroetano
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
BR9606925A (pt) Utilização de compostos e processo para o tratamento e profilaxia da obesidade
BR9408156A (pt) Método para tratamento quimico de rejeitos
BR9606766A (pt) Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais
BR9611901A (pt) Processo para o diagnóstico e a terapia de carcinomas epiteliais de placas
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
BR9407998A (pt) Instalaçao para o tratamento de matérias biológicas hidratadas
BR9002081A (pt) Processo e aparelho para o tratamento de detritos organicos
PT719499E (pt) Processo de tratamento anti-germinativo de tuberculos ou bolbos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]